Search results for "Highlights"
Influenza vaccination decreased risk of influenza hospitalization in patients with diabetes
On average during six influenza seasons, the protective effect of the vaccine in preventing influenza hospitalization was 46% for current-season vaccination and 44% for vaccination in prior seasons only, a Spanish study found.
https://diabetes.acponline.org/archives/2020/06/12/4.htm
12 Jun 2020
Preop metformin associated with better postop outcomes in type 2 diabetes
A retrospective cohort study used electronic health record data from one health care system to assess postoperative mortality and readmission rates in adults who had major surgery.
https://diabetes.acponline.org/archives/2020/05/08/3.htm
8 May 2020
Quarter of U.S. diabetes patients report using at least one strategy to reduce drug costs
In a survey of U.S. adults with diabetes, about 13% who were prescribed medication said they did not take it as prescribed, and about 24% said they asked their doctors for a lower-cost medication.
https://diabetes.acponline.org/archives/2019/09/13/2.htm
13 Sep 2019
Few diabetes, hypertension patients get recommended testing for kidney disease
Only 21% of patients with diabetes, hypertension, or both underwent urine albumin-to-creatinine ratio testing in a year, despite guideline recommendations, a large recent study found.
https://diabetes.acponline.org/archives/2021/08/13/1.htm
13 Aug 2021
Patients with type 1 diabetes spending more on supplies than insulin
Mean out-of-pocket spending for all care among a national sample of insured patients with type 1 diabetes was nearly $2,500 in 2018, according to one study, while a second study found that commercially insured patients' out-of-pocket insulin costs have peaked.
https://diabetes.acponline.org/archives/2020/06/12/3.htm
12 Jun 2020
Health care organizations push for diabetes self-management education and support
A new consensus report urged clinicians to discuss self-management education and support with all diabetes patients and provide referrals at four critical points in care, including diagnosis.
https://diabetes.acponline.org/archives/2020/06/12/2.htm
12 Jun 2020
SGLT-2 inhibitors associated with fewer serious renal events than DPP-4 inhibitors
In a propensity-matched Scandinavian study, new users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had a lower risk of renal replacement therapy and hospital admission for renal events than new users of dipeptidyl peptidase-4 (DPP-4) inhibitors.
https://diabetes.acponline.org/archives/2020/05/08/2.htm
8 May 2020
Diabetes associated with significantly increased risk of mortality in cardiomyopathy
Patients with diabetes and mild-to-moderate cardiomyopathy had higher mortality risk than nondiabetic patients with severe cardiomyopathy, suggesting that they may benefit from implantable cardioverter defibrillators, according to the study authors.
https://diabetes.acponline.org/archives/2020/03/13/2.htm
13 Mar 2020
ADA updates 2021 Standards of Care to address latest research on diagnosis, treatment
The American Diabetes Association (ADA) 2021 Standards of Medical Care in Diabetes now reflect new data on teplizumab and sodium-glucose cotransporter-2 inhibitors, as well as the effects of dapagliflozin and finerenone on patients with chronic kidney disease.
https://diabetes.acponline.org/archives/2021/07/09/1.htm
9 Jul 2021
Oral semaglutide led to greater reductions in HbA1c, body weight than sitagliptin
The industry-funded PIONEER 3 trial randomized adults whose type 2 diabetes was uncontrolled with metformin, with or without sulfonylurea, to receive either oral sitagliptin (100 mg/d) or oral semaglutide (3, 7, or 14 mg/d).
https://diabetes.acponline.org/archives/2019/04/05/2.htm
5 Apr 2019